Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with effusion. Some studies have reported the effects of montelukast and mometasone nasal spray in treatment of otitis media with effusion. However, current information is inadequate in this issue. The aim of this study was to compare the effectiveness of montelukast and mometasone nasal spray in treatment of otitis media with effusion in children attending Koodakan hospital in Bandar Abbas, Iran.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Montelukast | Experimental | 4 ml monteleukast daily for one month |
|
| Mometasone | Active Comparator | Inhaled mometasone 1 puff in each side of nose for one month |
|
| Control | No Intervention | No intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Monteleukast | Drug | 4 ml monteleukast daily for one month |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Treatment response | Defined as complete, partial, or no response based on the physician examination | 1 months |
| Measure | Description | Time Frame |
|---|---|---|
| Drug side effects | Frequency of Drug side effects as reported by the children or their parents | 1 month |
Not provided
Inclusion Criteria:
• Children who were between 2 to 6 years old
Exclusion Criteria:
• Currently were using corticosteroids or prophylactic monteleukast
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hamidreza Mahboobi, M.D | Hormozgan University of Medical Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hormozgan University of Medical Sciences | Bandar Abbas | Hormozgan | 097145-3388 | Iran |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38088821 | Derived | Mulvaney CA, Galbraith K, Webster KE, Rana M, Connolly R, Tudor-Green B, Marom T, Daniel M, Venekamp RP, Schilder AG, MacKeith S. Topical and oral steroids for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2023 Dec 13;12(12):CD015255. doi: 10.1002/14651858.CD015255.pub2. | |
| 28894551 | Derived |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000068656 | Mometasone Furoate |
| ID | Term |
|---|---|
| D011244 | Pregnadienediols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Mometasone |
| Drug |
Inhaled mometasone 1 puff in each side of nose for one month |
|
| Rahmati MB, Safdarian F, Shiroui B, Zare S, Sadeghi N. Montelukast versus inhaled mometasone for treatment of otitis media with effusion in children: A randomized controlled trial. Electron Physician. 2017 Jul 25;9(7):4890-4894. doi: 10.19082/4890. eCollection 2017 Jul. |
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |